Ameriprise
SION

Ameriprise’s Sionna Therapeutics SION Stock Holding History

Ameriprise’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62M Buy
82,232
+258
+0.3% +$10.3K ﹤0.01% 2772
2026
Q1 		$3.29M Sell
81,974
-19,669
-19% -$751K ﹤0.01% 2701
2025
Q4 		$4.18M Sell
101,643
-51,508
-34% -$1.95M ﹤0.01% 2563
2025
Q3 		$4.5M Sell
153,151
-83,662
-35% -$1.82M ﹤0.01% 2518
2025
Q2 		$4.11M Buy
236,813
+27,547
+13% +$361K ﹤0.01% 2508
2025
Q1 		$2.19M Buy
+209,266
New +$3.42M ﹤0.01% 2848

Other funds holding SION

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Ameriprise's SION Position: Q2 2026 in Review

Ameriprise increased its Sionna Therapeutics (SION) stake by 0.31% in Q2 2026, buying an estimated $10.3K and bringing the position to 82,232 shares worth $3.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2772.

Ameriprise first reported a position in SION in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.5M in Q3 2025. 146 funds tracked by Wall St. Rank hold SION as of Q2 2026.

  • Ameriprise held 82,232 shares of Sionna Therapeutics worth $3.62M as of Q2 2026.
  • Ameriprise bought 258 Sionna Therapeutics shares in Q2 2026, an estimated $10.3K.
  • Sionna Therapeutics made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2772 holding.
  • Ameriprise first reported a position in Sionna Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Ameriprise's Sionna Therapeutics position peaked at $4.5M in Q3 2025.
  • 146 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.